End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.78 CNY | -1.19% |
|
+4.00% | -9.84% |
07-08 | Hengrui Medicine Gets Inspection Clearance from Jiangsu Province's Drug Regulator | MT |
07-05 | Jiangsu Hengrui Medicine Gets Clinical Trial Approval for Pulmonary Fibrosis Drug | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.84% | 35.74B | |
+63.05% | 856B | |
+39.05% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.77% | 244B | |
+5.03% | 234B | |
+16.61% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Jiangsu Hengrui Medicine Gets Clinical Trial Approval for Pulmonary Fibrosis Drug